Edwards Lifesciences ROA 2010-2022 | EW

Current and historical return on assets (ROA) values for Edwards Lifesciences (EW) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Edwards Lifesciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2022-09-30 $1.46B $8.64B 17.17%
2022-06-30 $1.46B $8.43B 17.37%
2022-03-31 $1.54B $8.42B 18.80%
2021-12-31 $1.50B $8.50B 19.06%
2021-09-30 $1.48B $8.16B 19.53%
2021-06-30 $1.46B $7.66B 20.24%
2021-03-31 $0.85B $7.21B 12.30%
2020-12-31 $0.82B $7.24B 12.42%
2020-09-30 $0.79B $6.80B 12.32%
2020-06-30 $0.74B $6.42B 11.93%
2020-03-31 $1.11B $6.08B 18.39%
2019-12-31 $1.05B $6.49B 17.82%
2019-09-30 $0.77B $5.97B 13.86%
2019-06-30 $0.73B $5.57B 12.99%
2019-03-31 $0.77B $5.47B 13.66%
2018-12-31 $0.72B $5.32B 12.69%
2018-09-30 $0.71B $5.96B 12.33%
2018-06-30 $0.66B $5.69B 11.59%
2018-03-31 $0.56B $5.83B 10.13%
2017-12-31 $0.58B $5.67B 11.07%
2017-09-30 $0.75B $5.49B 14.96%
2017-06-30 $0.72B $5.14B 15.26%
2017-03-31 $0.66B $4.78B 14.86%
2016-12-31 $0.57B $4.51B 13.61%
2016-09-30 $0.55B $4.34B 13.55%
2016-06-30 $0.53B $4.05B 13.36%
2016-03-31 $0.52B $3.85B 13.38%
2015-12-31 $0.50B $4.06B 13.17%
2015-09-30 $0.46B $3.88B 12.78%
2015-06-30 $0.44B $3.61B 12.60%
2015-03-31 $0.87B $3.49B 25.54%
2014-12-31 $0.81B $3.52B 25.24%
2014-09-30 $0.78B $3.35B 25.82%
2014-06-30 $0.76B $3.33B 27.06%
2014-03-31 $0.31B $2.65B 11.92%
2013-12-31 $0.39B $2.71B 15.75%
2013-09-30 $0.40B $2.53B 17.17%
2013-06-30 $0.40B $2.34B 17.45%
2013-03-31 $0.37B $2.30B 16.84%
2012-12-31 $0.29B $2.22B 13.70%
2012-09-30 $0.27B $2.20B 12.84%
2012-06-30 $0.25B $2.08B 12.33%
2012-03-31 $0.24B $2.00B 11.94%
2011-12-31 $0.24B $1.98B 12.00%
2011-09-30 $0.24B $1.98B 12.44%
2011-06-30 $0.24B $2.00B 12.66%
2011-03-31 $0.24B $1.93B 13.31%
2010-12-31 $0.22B $1.77B 13.00%
2010-09-30 $0.20B $1.73B 12.27%
2010-06-30 $0.23B $1.64B 14.11%
2010-03-31 $0.22B $1.60B 13.87%
2009-12-31 $0.23B $1.62B 15.29%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $47.328B $5.233B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.378B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00